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Increasing our understanding of Earth’s biodiversity and responsibly stewarding its resources are among the most crucial sci-
entific and social challenges of the new millennium. These challenges require fundamental new knowledge of the organization,
evolution, functions and interactions among millions of the planet’s organisms. Herein we present a perspective on the Earth
BioGenome Project (EBP), a Moon Shot for biology that aims to sequence, catalog and characterize the genomes of all of Earth’s
eukaryotic biodiversity over a period of ten years. The outcomes of the EBP will inform a broad range of major issues facing
humanity, such as the impact of climate change on biodiversity, the conservation of endangered species and ecosystems, and
the preservation and enhancement of ecosystem services. We describe hurdles the project faces, including data sharing policies
that ensure a permanent, freely-available resource for future scientific discovery while respecting Access and Benefit Sharing
guidelines of the Nagoya Protocol. We also describe scientific and organizational challenges in executing such an ambitious
project, and the structure proposed to achieve the project’s goals. The far-reaching potential benefits of creating an open digital
repository of genomic information for life on Earth can be realized only by a coordinated international effort.
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“Our task now is to resynthesize biology; put the organism
back into its environment; connect it again to its evolutionary
past; and let us feel that complex flow that is organism, evolution,
and environment united.”
New Biology for a New Century, Carl R. Woese
Biodiversity: a threatened global resource provides a call
to action
We are only just beginning to understand the full majesty of
life on Earth (1). Although 10 to 15 million eukaryotic species
and perhaps trillions of bacterial and archaeal species adorn
the Tree of Life, approximately 2.3 million are actually known
(2) and, of those, fewer than 15,000, mostly microbes, have
completed or partially-sequenced genomes (Fig. 1). From this
small fraction of Earth’s known biome, a significant portion of
modern knowledge in biology and the life sciences has emerged.
This foundational knowledge has facilitated enormous advances
in agriculture, medicine and bio-based industries, and enhanced
approaches for conservation of endangered species.
Despite these great advances, the world’s biodiversity is
largely uncharacterized and increasingly threatened by climate
change, habitat destruction, species exploitation, and other
human-related activities. The Living Planet Index reported a
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58% decline in vertebrate populations during the 42-year period
1970-2012 (3), and the International Union for Conservation
of Nature (IUCN) estimated that 23,000 of 80,000 species
surveyed are approaching extinction (4). We are in the midst of
the 6th great extinction event of life on our planet (5), which
not only threatens wildlife species but also imperils the global
food supply (6). By the year 2050, up to 50% of existing species
may become extinct mainly due to natural resource-intensive
industries (5). Humanity faces the question of how such massive
losses of species diversity will affect the complex ecosystems that
sustain life on Earth, including our ability to derive the foods,
biomaterials, bioenergy, and medicines necessary to support
an expected human population of 9.6 billion by 2050. Ecosys-
tem collapse on a global scale is a real possibility, making the
preservation and conservation of terrestrial, marine, freshwater,
desert and agricultural ecosystems a global imperative for human
survival and prosperity.
Unimaginable biological secrets are held in the genomes of
the millions of known and unknown organisms on our planet.
This “dark matter” of biology could hold the key to unlocking
the potential for sustaining planetary ecosystems upon which we






















































































































Fig. 1. Current status of the sequencing of life. Open Tree of Life
(opentreeoflife.org) synthesis phylogeny of all of life with resolution to
the genus level showing phylogenetic information for Archaea (red),
Bacteria (purple), Fungi (orange), Plantae (blue), Protista (brown) and
Animalia (green). We show the current state of genomic information
available through NCBI’s GenBank in the inner circle with complete
genomes colored in red, chromosome level in blue, scaffolds in dark
grey and contigs in light grey. The second circle shows the tran-
scriptomes available through the NCBI Transcriptome Shotgun Assem-
bly Sequence Database (https://www.ncbi.nlm.nih.gov/genbank/tsa/).
Genome size as C-value is displayed in bars around the outer cir-
cle, with data for animals extracted from the Animal Genome Size
Database (http://www.genomesize.com/), for plants, from the Royal
Botanic Gardens, Kew (http://data.kew.org/cvalues/), and for fungi,
from the Fungal Genome Size Database (http://www.zbi.ee/fungal-
genomesize/).
Table 1. Genomics-enabled discoveries and applications.
Taxon Application
Humans disease diagnostics; disease risk; human ancestry; drug
design; personalized medicine; forensics
Livestock &
wildlife
disease diagnostics; genomic selection for milk yield,
carcass composition; parentage control; conservation
of endangered breeds and species; disease models
Plants genomic selection to improve crop yields and other
agronomically-important traits; biofuels production;
gene editing; conservation of endangered species
Insects gene drives; genome editing; pest control
Fungi synthetic biology; metabolic engineering for drug
production and useful chemicals; biofuels production,
improved strains for making wine and beer
Bacteria microbiome in health and disease; bioprocessing;
detection, surveillance and host response; genomic
epidemiology; understanding microbial diversity
Viruses vaccines; gene editing; metagenomics screening
population. For example, from invertebrates such as sponges,
mollusks, tunicates, and cone snails, several FDA-approved drugs
Table 2. Goals of the Earth BioGenome Project.
Revise and reinvigorate our understanding of biology, ecosystems
and evolution
Better understand evolutionary relationships among all known
organisms
Fully elucidate the timing, origin, distribution and density of
species on Earth
Generate new knowledge ecosystem composition and functions
Discover new species (80-90% of eukaryote biodiversity)
Elucidate genome evolution (gene to chromosome scale)
Discover fundamental laws that describe and drive evolutionary
processes
Enable the conservation, protection, and regeneration of
biodiversity
Determine the role of climate change on biodiversity
Clarify how human activities (pollution, habitat encroachment,
etc.) and invasive species affect biodiversity
Develop evidence-based conservation plans for rare and
endangered species
Create genomic resources to restore damaged or depleted
ecosystems
Maximize returns to society and human welfare (ecosystem services
and biological assets)
Discover new medicinal resources for human health
Enhance control of pandemics
Identify new genetic variation for improving agriculture (e.g.,
yields, disease resistance)
Discover novel biomaterials, new energy sources and biochemical
Improve environmental quality (soil, air and water)
Table 3. Organized communities conducting large-scale genome
projects.
Community Lead Center(s) Sequencing goal
G10K BGI, Rockefeller University,








GAGA BGI 300 ant genera
I5K Baylor College of Medicine 5,000 arthropods
1000 Fungal
Genomes Project
DOE Joint Genome Institute 1,000 fungal
species
































































































































Fig. 2. Proposed roadmap for the Earth BioGenome Project.
have been developed for treating cancer (e.g., cytarabine, initially
isolated from a sponge), virus infections, and pain (7). More
than 25 marine-derived drugs are in preclinical or clinical trials.
Fungi are the basis for fermentation to produce wine, beer and
bread, and knowledge gained from yeast genomics has led to
improved production strains for brewers, vintners and bioenergy
production from waste streams. From the more than 391,000
known species of plants (https://stateoftheworldsplants.com/2-
016/), hundreds of drugs for treating pain (e.g., opiates) and
chronic diseases, including cancer (e.g., taxol), have been pro-
duced and commercialized. Plants are also the basis of large
industries, such as food, rubber and second-generation bio-
ethanol production. Thus, sequencing and annotating the vast
number of previously uncharacterized genomes will continue to
result in the discovery of many new useful genes, proteins, and
novel metabolic pathways. These organisms and their genomes
will provide the raw materials for genome engineering and
synthetic biology approaches to produce valuable bio-products
at industrial scale, as has been accomplished for artemisinin,
which is used to treat malaria and nematode infections (8).
Sustainable production of goods and bio-inspired materials is the
foundation for a healthy planet, especially as humanity transitions
from petrochemical inputs to reduce carbon emissions and other
greenhouse gases.
Many pioneering discoveries have been made using species
across the phylogenetic spectrum as a direct result of the ge-
nomics revolution. With initial efforts focused primarily on our
own species, the United States government’s initial investment
of $3 billion to sequence and annotate the human genome,
plus significant contributions from the Wellcome Trust and other
international funding bodies, resulted in an entirely new field of
medicine and more than $1 trillion of direct economic benefit (9).
Driven by the technological advances made during the Human
Genome Project, sequencing of other genomes across the Tree
of Life have contributed to expanding scientific knowledge and
the global economy (Table 1).
Sequencing All Eukaryotic Life: Why Now?
Powerful advances in genome sequencing technology, infor-
matics, automation, and artificial intelligence, have propelled
humankind to the threshold of a new beginning in understanding,
utilizing, and conserving biodiversity. For the first time in history,
it is possible to efficiently sequence the genomes of all known
species, and to use genomics to help discover the remaining 80
to 90 percent of species that are currently hidden from science.
While organized efforts are underway to sequence Bacteria and
Archaea (e.g. (10)), there is currently no parallel effort for the
Eukarya.
A conceptual argument for sequencing eukaryotic life was
made by Stephen Richards in 2015 (11). Richards argued that
current technology would permit sequencing a vast number of
species, and a phylogenetic approach to stratifying samples for
sequencing would accelerate scientific discovery. Independently,
in November 2015, an exploratory meeting that included rep-
resentatives from research universities and major international
and U.S. federal funding agencies (SI Table S1) was held at






























































































































Submission PDFFig. 3. Earth BioGenome Project organizational model. The schematicshows the main features of the proposed organizational model for the
EBP as a global network of communities. The outer ring of shows a
global network of interacting nodes involved in DNA sequencing and
informatics. The geographical locations are representative and not
intended to be completely inclusive of all participating countries or
political entities. The communities in the inner ring are also representa-
tive and not intended to be inclusive of all taxon-related communities
and organizations that are supporting the goals of the EBP. The EBP
Coordinating Council will have representation from all participating
nodes, communities and organizations, as well as representation from
the public and private sectors. GGBN, Global Genome Biodiversity
Network; GGI, Global Genome Initiative; GIGA, Global Invertebrate
Genomics Alliance; i5K, GAGA, Global Ant Genome Alliance; Initiative
to Sequence 5000 Arthropod Genomes; G10K; Initiative to Sequence
10,000 Vertebrate Genomes; 1KP; Initiative to Sequence 1000 Plant
Genomes.
and feasibility of sequencing all life on Earth, a venture termed
The Earth BioGenome Project (EBP). The consensus view that
emerged from the meeting was that the time was right to con-
sider a global initiative to sequence eukaryotic life on Earth. A
subsequent EBP workshop and a major conference on genomics
and biodiversity organized by the Smithsonian Institution and
BGI (China) were held in Washington, D.C., in February, 2017.
There, the EBP Working Group endorsed a project roadmap and
organizational structure for completion of the sequencing aspect
of the project in 10 years (12) as described below.
One of the key strategic issues for the EBP is the goal of se-
quencing every species as opposed to one representative mem-
ber of each family or genus. This important objective requires a
strong rationale to justify the cost. Evolution, co-evolution and
conservation ultimately occur at the species level, and ecology
is defined by the interactions among species. Therefore, under-
standing evolutionary and other biological processes, such as
adaptation, speciation, the fate of endangered species, the rea-
sons for extinctions, the importance of species to the functioning
of ecosystems, and the possibility of restoring ecosystems critical
to human survival, all require knowledge at the species level.
In modern biology, the most powerful way to gain insights into
the origins, evolution and biological functions of a species is
through genomics. Moreover, taxonomy is a human construct,
even when based on phylogeny, and the number of species in a
recognized taxon is in part historical artifact and convenience as
well as the product of evolution. Consider, for example, the genus
Candida, which includes about 25% of all known yeast species.
Some species are important human pathogens, while others are
associated with wine spoilage. The metabolic and phenotypic
diversity in this genus is enormous, and no single species can
possibly represent the unique biology contained within it. Similar
taxonomic diversity exists in plants, such as the genus Astragalus
with more than 3,200 species. In insects, one order alone, the
Coleoptera (beetles), has nearly 400,000 identified species in
30,000 genera across 176 families, which represents about 25%
of all classified eukaryotic life, with a predicted 1.5 million beetle
species inhabiting the planet (13). Sampling just one species
per genus or family would not give a realistic assessment of the
evolutionary complexity of these, or many other, groups. While
recognizing that it may not be feasible to obtain samples for every
species, pragmatism does not negate the primary scientific and
societal need for trying to do so.
Project Goals and Anticipated Outcomes
Revise and reinvigorate our understanding of biology and
evolution. The EBP has identified a broad set of scientific goals
and projected economic, social, and environmental returns to
society and human welfare (Table 2). These goals require assem-
bled whole genome sequences collected in a robust Tree of Life
framework (2) to derive the fundamental evolutionary principles
that drive eukaryotic genomic and phenotypic evolution. As of
October 2017, there were only 2,534 unique eukaryotic species
with sequenced genomes in the National Center for Biotech-
nology Information (NCBI) database, which is less than 0.2% of
the known eukaryotes. Moreover, of these, only 25 species meet
the standard for contig N50, scaffold N50, and other metrics
proposed for reference genomes by the G10K organization (SI
Fig. S1; SI Fig. S2). At all levels of assembly quality, only 25
species, mostly fungi, are assembled to “complete genome” sta-
tus as defined by NCBI. The phylogenetic distribution of existing
reference quality assemblies is also highly skewed, with only
seven eukaryotic phyla represented. Thus, there is a critical need
to obtain annotated genomes from across the eukaryotic Tree
of Life to answer important scientific questions and to provide a
solid foundation for future biological discoveries and innovations.
In fact, the eukaryotic Tree of Life itself is poorly understood, and
large-scale phylogenetic syntheses have resolved or validated
only a small fraction of polytomies (2). Thus, the EBP will not only
take advantage of a phylogenetic framework, but will contribute
significantly to a better understanding of how all biological di-
versity is related, as well as the relative and absolute timing of
diversification events (14).
Many questions can only be answered if all genomes of a
single group of organisms are available (15). One of these scien-
tific challenges is to resolve conflicting phylogenetic relationships
in the eukaryotic Tree of Life, especially among the deepest
branches (16). Whole genome sequences may be particularly
powerful in this regard, because problems arising in phyloge-
netic tree topologies from the use of small numbers of genes
can be resolved (16, 17). Whole genome sequencing allows for
selection of the most informative gene set for accurate phylo-
genetic inference. A complete set of sequenced and annotated
eukaryotic genomes will also greatly expand our knowledge and































































































































horizontal gene transfer on eukaryote phylogenomic analyses,
and their functional role in eukaryote evolution. A well-supported
eukaryotic Tree of Life is essential for properly classifying the
millions of presently undiscovered, unnamed, and unclassified
organisms as their genome sequences become available. We
anticipate that new methods for whole genome sequencing of
unicellular organisms (18) will contribute to the discovery of
new eukaryotic species and their correct taxonomic classification,
insights into divergence times, and ultimately resolving some of
the most contentious phylogenetic relationships in the Tree of
Life.
Another major scientific challenge that will be addressed is
the understanding of how genomes evolve, from the base-pair
to the chromosome level. Sequencing genomes of extant species
will enable reconstruction of the evolutionary history of eukaryotic
genomes from a computed ancestral state (19, 20). The evolution-
ary history of point mutations, duplications, deletions, insertions,
translocations, inversions, fusions, and fissions is crucial to our
understanding of the relationships between genotype and phe-
notype (21), and the changes in genomic architecture that led
to multicellularity and organismal complexity. The computational
reconstruction of the karyotype of the ancestral eukaryote and
key ancestral genomes on the evolutionary paths to higher taxa
will enhance understanding of the evolution of genes in the
context of their surrounding regulatory DNA and enable reso-
lution of long-standing controversies on the role of chromosome
rearrangement in adaptive evolution and speciation (19, 22).
Facilitate the conservation, protection, and regeneration of
biodiversity. There is a clear and urgent need to understand
the impact of natural and human factors on biodiversity. Climate
change and habitat destruction are having tremendous impacts
on both marine and terrestrial ecosystems (23). We know that
species numbers and diversity are rapidly declining, but other
than storing germplasm in frozen collections in the event of a
natural or human-induced disaster, limited means are available to
systematically preserve, protect, and restore endangered species
in the wild. Therefore, resources are needed to uncover and
better document genomic diversity, especially of endangered
species. Sampling genomic diversity in populations reveals the
frequency and distribution of genetic polymorphisms as baseline
data on population fitness necessary for the design of con-
servation programs (reviewed in (24)). In endangered species
with severely reduced populations, breeding programs based on
genomic data from a few individuals can be implemented that
avoid inbreeding, eliminate recessive lethal alleles, and increase
disease resistance (25). Although much can be learned by se-
quencing a single diploid or polyploid individual, characterization
of genomic diversity of the more than 23,000 species currently
listed as endangered by IUCN is a high priority and a goal of
the EBP. The Earth BioGenome Project will spur development
of urgently needed new conservation management approaches
based on genomic diversity of endangered species.
In addition to a taxonomically driven format for sequencing
genomes, the EBP also will work to establish bio-observatories
that use genomics to obtain a baseline understanding
of how climate change affects global biodiversity. These
observatories are especially critical in areas that have large
numbers of endangered species. A network of instrumented
bio-observatories in biodiversity hotspots can provide real-
time information on species numbers, distribution and
fluxes. We anticipate that some needs can be met by the
National Ecological Observatory Network (NEON) created
by the U.S. National Science Foundation, its counterpart
in China (the Chinese Ecological Research Network;
http://english.iae.cas.cn/rh/as/201311/t20131121 113005.html),
the plot-based ForestGEO (http://www.forestgeo.si.edu/)
and MarineGEO (https://marinegeo.si.edu/) programs at the
Smithsonian Institution, and other national and international
networks. Local resources, such as those developed by
the UC California Conservation Genomics Consortium
(https://ucconservationgenomics.eeb.ucla.edu/), will also be
essential. Substantial opportunities will be afforded to students
and citizens of all ages to participate in the monitoring of
biodiversity, discovery of new species, and collection of
environmental DNA (eDNA) samples, thus increasing public
interest and participation in the EBP.
Monitoring organismal diversity in bio-observatories, partic-
ularly in remote locations, will spur development and use of
new technologies, such as portable DNA sequencers, advanced
sensor technologies, and secure bio-data transmission. Efficient
technologies have already been created for identifying and
categorizing species in their native habitats based on short
DNA segments (26). The EBP will coordinate its activities with
such organizations as the International Barcode of Life (iBOL;
http://www.ibolproject.org/), the Global Genome Biodiversity
Network (GGBN) (27), and major biodiversity collections around
the world to contribute large numbers of new vouchered species
for the barcoding effort and eventual whole genome sequencing.
A digital repository of annotated eukaryotic genome sequences
will facilitate new methods and approaches for studying genomic
ecology at different spatial and temporal scales, which is neces-
sary for obtaining a multidimensional and dynamic view of life on
Earth.
Maximize returns to society and human welfare. The myr-
iad ways by which ecosystems and the biodiversity comprising
them contribute to the benefit of society and human welfare
are termed ecosystem services. These services employ the full
range of nature’s natural products and materials and also serve
as a template for imitating nature’s biological functions and
processes. The human population explosion and the rapid spread
of medical and agricultural pests and diseases as a result of
global interconnectivity are compelling examples of the need
for new resources that will contribute to feeding, protecting, and
improving Earth’s ecosystems. An urgent demand exists for new
sources of food proteins that can be produced cheaply and at
scale, new medicines for treating the increasing frequency of
chronic diseases plaguing human populations, new strategies for
controlling outbreaks of zoonotic diseases, and new resources
for maintaining and improving the quality of soil, air and water.
With less than 0.2% of known eukaryotic genomes sequenced,
most at draft level, and only a small fraction of nature’s 285,000
known natural compounds replicated in the laboratory, we have
barely scratched the surface in identifying new genetic resources
for delivery of ecosystem services. Thus, the full value of nature,
in particular our tropical forests and other biodiversity-rich hot
spots, is likely to be grossly underestimated. Annual revenues in
the U.S. alone from genetically engineered plants and microbes
are estimated at more than $300 billion, or about 2% of gross
domestic product (28). Obtaining the genetic blueprints for all
eukaryotic life, and eventually the vast numbers of Bacteria and
Archaea, will create a powerful source of discovery for improving































































































































A 10-year Road Map
The successful, systematic sequencing of all life on Earth
will not be possible without an organized and sustained effort.
Although geographic and taxon-based communities are working
on related initiatives, few of them are coordinated with each
other, andmost are not focused on whole genome sequencing. A
global “network of communities,” proposed as an EBP organiza-
tional structure (see below), is a realistic strategy for achieving the
grand challenge goal of sequencing all life on Earth. Among the
examples of organized taxon-based communities, those working
on cultured and uncultured Bacteria and Archaea are benefitting
from well-defined objectives and global funding sources. The
National Microbiome Initiative (NMI) was launched in 2016 by the
U.S. Office of Science and Technology Policy and is supported by
$121 million from multiple stakeholder federal agencies (29). The
NMI will receive an additional $400million in support from private
companies and philanthropies. The Earth Microbiome Project
is an ambitious parallel global effort to characterize microbial
diversity (10).
Because the scientific communities that work on Bacteria and
Archaea are relatively well-organized by taxon, the EBP Working
Group decided to similarly focus its planning effort on sequenc-
ing all eukaryotes using a taxonomically driven format. Although
several taxon-based initiatives for sequencing the genomes of
eukaryotic species exist (Table 3), a common strategy is lacking
among these groups, and large swaths of the eukaryotic Tree of
Life are not represented. The EBP Working Group has focused
specifically on a strategy and justification to sequence and anno-
tate all eukaryotic genomes, including vertebrates, invertebrates,
plants, fungi, and microbial eukaryotes, among others. In this
paper, we have explored the rationale, feasibility and challenges
associated with sequencing eukaryotes almost exclusively, but
the ultimate goal of the EBP is to work with other organizations
to support sequencing of the full diversity of life on Earth.
The EBP roadmap calls for sequencing and annotating 1.5
million known eukaryotic species in three phases over a 10-year
period using a phylogenomic approach (Fig. 2). During the three
years of phase I, one of the most important goals is to create
annotated chromosome-scale reference assemblies for at least
one representative species of each of the 9,000 eukaryotic
taxonomic families. Nucleotide divergence and divergence time
will be additional factors in the selection of species so that
balance across eukaryotic taxa is achieved. High-quality reference
assemblies (minimum standard of 2.3.2.Qv40; see SI Fig. S1) at
the family level will ensure robustness of comparative genomic
analyses by providing complete gene sets as well as ordered
and oriented syntenic blocks created by genome scaffolding
methods (15, 19). In addition, these genomes will be useful
for classification of extant and new species, identifying genetic
changes associated with specialized traits in specific lineages, in
silico reference-assisted scaffolding of assemblies produced in
phase II and phase III of the project (30), in silico reconstruction of
ancestral genomes, and rescue of species from extinction (15, 31).
A full description of the roadmap, overall strategy, and estimated
costs can be found in the Appendix, Supplementary Text.
Challenges and Opportunities
Sample acquisition. The EBP will fully catalog the genome
content of eukaryotic biodiversity and make the data openly
available as a permanent foundation for future scientific dis-
covery whilst ensuring compliance with the Nagoya Protocol,
as discussed below. The main challenge is the development of
a global strategy for the collection of voucher specimens that
are preserved adequately to enable production of high-quality
genome assemblies. The distributed nature of Earth’s biodiversity
and the location of biodiversity hotspots in remote parts of the
world, such as the Amazon Basin or Borneo, makes collection of
many organisms a distinct challenge. For the EBP to be successful
it is crucial to involve institutions whose mission it is to procure
and preserve the world’s biodiversity, such as natural history
museums, botanical gardens, zoos, and aquaria . For example,
the collections of the botanical gardens of the world comprise
about one third of all species of plants and more than 40% of
all endangered plant species (32), which will be an invaluable
resource for the EBP. The EBP also has GGBN as a committed
partner, which is the world’s major resource of tissues and DNA
from voucher specimens (see SI Supplementary Text). It will be
essential to involve scientists in countries where a significant frac-
tion of the world’s biodiversity resides, such as Brazil, Colombia,
Peru, Madagascar, Malaysia, and Indonesia. A goal of the EBP
is to globalize its activities through novel partnerships that build
scientific capacity in developing countries, including the capacity
to utilize, not just create, our shared genomics legacy.
To accelerate the acquisition of voucher specimens, the EBP
also plans to capitalize on the burgeoning citizen scientist move-
ment (fueled by the internet and social media) and new au-
tonomous robotic technologies. There is an exciting opportunity
for citizen science to contribute to collecting and identifying
sequence-ready specimens and performing data analysis. For
example, the University of California Conservation Genomics
Consortium’s CALeDNA program (http://www.ucedna.com) will
involve 1,000 citizen scientists who will collect 18,000 environ-
mental samples by the end of 2018. Radically new technolo-
gies may be developed and deployed for sample collection,
such as the use of aerial, terrestrial and aquatic autonomous
drones equipped with high-resolution cameras that can enable
species collection and identification, and telecommunications
with taxonomic experts (33). Conceivably, such robotic devices
can also be equipped with automated DNA extraction devices
and portable DNA sequencers for rapid species identification.
The development of such robots is feasible given the current state
of relevant technologies, and offers an excellent opportunity for
interdisciplinary collaboration and breakthrough innovation.
A special challenge for the EBP will be obtaining whole
genome sequence information from cultured and uncultured
single cell eukaryotes. For example, there are more than
34,000 known and perhaps 107,000 unidentified species in the
Chromista and Protista Kingdoms (34). Sequencing of microbial
eukaryotes will be paramount for resolving the phylogenies within
the Protista and Chromista, and for understanding how early
eukaryotic life evolved. As discussed above, recent advances
in single cell sequencing technology (18) have opened new
horizons for understanding microbial evolution. The methods
involve separating single cells using flow cytometry, in situ lysis
in micro-well plates, and whole genome amplification followed
by library production and sequencing (18). At present, genome
coverage varies significantly, but technological improvements are
now yielding genomes with up to 80% coverage. The usefulness
of single cell genomics in elucidating undiscovered microbial life
has been demonstrated for Bacteria and Archaea (35) and should
































































































































Computation and Data Science. The EBP will generate op-
portunities and challenges for new tools to visualize, compare
and understand the connection of genome sequence to the
evolution of phenotype, organism and ecosystems. It is note-
worthy that for storing sequence reads, assembling reads into
genome sequences, aligning the genomes of related species,
and annotating gene models, the computational challenge has
already been surmounted by the information industry. For exam-
ple, storage and distribution of reference genomes, annotations
and analyses will likely require less than 10 Gigabytes per species
or 20 Petabytes in total (see SI Supplementary Text), well within
current capabilities of the International Nucleotide Sequence
Database Collaboration of NCBI, EMBL-EBI and DDBJ. Storage
of the underlying sequence read data for the completed EBP
is more challenging at 200 Petabytes (see SI Supplementary
Text for calculations). Commercial vendors and at least one
academic project (CERN) have already surpassed this storage
capacity (https://home.cern/about/updates/2017/07/cern-data-
centre-passes-200-petabyte-milestone). Furthermore, we expect
costs and capabilities to improve before the highest data gen-
eration years of the project. There are new technologies on the
horizon that will help support genome storage needs, including
3-D memory, integrated computing technologies that overcome
the I/O bottleneck, and faster networks enhanced by optical
switching (36).
Similarly, computing requirements are very large but tractable.
Mammalian sized long read genome assemblies currently require
100 processor-weeks. The later phases of the EBP will require
10,000 simultaneous assemblies running in parallel – a scale
already approached by academic supercomputer centers such as
those at universities in Texas, Pittsburg, Illinois and San Diego,
and exceeded by commercial cloud providers such as AWS, Mi-
crosoft, Google, Alibaba, and others around the world. Although
current tools are already capable of completing the project, there
is no doubt that assembly, alignment, and annotation algorithms
implemented in both hardware and software will, in the future,
all need to be improved for efficiency, accuracy and application
to difficult genomes such as very large, very repetitive or very
polymorphic genomes.
The EBP promises the opportunity to envision and develop
new computational tools and analysis methods to maximize our
understanding and utilization of large amount of data generated
by the project. This challenge will require new architectures,
algorithms and software for improved quality, efficiency, and
cost effectiveness as well as data analysis, big data visualization
and sharing. For example, graph representations of diploid refer-
ences are required – especially for more polymorphic genomes
(37). New visualization tools enabling comparative inspection of
gene loci and synteny across the Tree of Life will be required.
We anticipate that annotation tools focused on a gene family
across many species using gene-specific knowledge (e.g., trans-
membrane domain or three-dimensional structure conservation)
will perform better than the current tools designed for the an-
notation of all genes. Comparative analyses could identify the
degree of selection on each base-pair in every species, enabling
the study of the evolution of gene regulation as well as gene and
protein structure. Building phylogenetic trees with genomic data
at this scale will require a new set of bioinformatics requirements
and a modular framework for integrating phylogenetic data and
computing on such trees. Better methods to visualize genome
evolution via structural changes, including segmental duplica-
tions, inversions, translocations, insertions and deletions, must
be created. In addition, improved methods to associate phe-
notype with change in comparative genome and transcriptome
sequence are needed. We also envision new tools for assess-
ing how protein sequence variation changes the efficiencies of
enzymes, the binding constants of molecular interactions and
the comparative systems biology of different eukaryotic cells
and tissues. Finally, the advances in computer science and the
internet have enabled new possibilities for large scale data shar-
ing, such as open access to the EBP’s computational “lab book.”
With a sufficiently rich platform, raw sequence data, assemblies,
alignments, phylogenetic trees and automated annotations can
be instantly disseminated. The EBP will promote these tools for
equitable worldwide sharing of data, analysis tools and data
mining resources.
Access and Benefit Sharing. In 2010, the Nagoya Protocol
provided guidelines on access to genetic resources as well as
fair and equitable sharing of benefits arising from their utilization
under the Convention on Biological Diversity (CBD). Nagoya, an
international convention, requires its member countries to create
laws and policies within their own legal systems to address points
outlined in the Convention. Thus, Nagoya is international but im-
plemented at the national level. The Convention sets “minimum
standards” and countries can go beyond those standards if they
wish. A number of important publications can be found on the
Nagoya Protocol and its associated impact on genetic research
and collections (e.g., (34, 38)). Most countries are still working
on their national implementations of Nagoya; however, some
uncertainty remains as to what the final legal requirements will
be.
Users of biological resources are now responsible for com-
plying with regulations on biodiversity use at the national level,
including those regulations associated with Access and Benefit
Sharing. The EBP will adhere to the principles of the Nagoya Pro-
tocol by: 1) requiring participants to comply with regulations on
biodiversity use at the national level, and 2) using the established
tools and resources on Access and Benefit Sharing. Specifically,
the EBP aims to provide fair, equitable, open and rapid access to,
and sharing of the benefits of, the eukaryotic genomes of planet
Earth.
In order to ensure proper documentation of genetic resources
and Access and Benefit Sharing compliance, the EBP will pro-
mote downstream monitoring and tracking of utilized genetic
and genomic resources. Systems for Access and Benefit Sharing
compliance have been developed to meet this need, both at
the national and international levels. For example, at the inter-
national level, the GGBN Data Standard (27, 39) was developed
for the exchange of information on genetic samples housed
in biological repositories globally. The Standard requires that
genetic samples provided for research by GGBNmember institu-
tions (i.e., non-human biological repositories) be associated with
permitting and other legal information associated with Access
and Benefit Sharing. At the national level, a new Brazilian law
(Law 13.123/15) expands the interpretation of “access to genetic
resources” to include research related to molecular taxonomy,
phylogeny, molecular ecology, and molecular epidemiology, as
well as the use of information from genetic sequences published
in databases. A national-level registration system, SisGen, allows
Brazilian biological material to be legally accessed and shipped
abroad for research and provides an interface for registration,































































































































systems will be essential for the success of the EBP.
Coordination and Governance
A Network of Scientific Expertise. Achieving the goals of
the EBP will require coordination on a global scale, as well as
scientific excellence and experienced leadership (Fig. 3). The EBP
Working Group, currently comprising this paper’s authors, has
well-known experts from the genomics, informatics, systematics,
evolutionary biology, biorepositories and conservation commu-
nities, an ethicist and an expert on innovation. Some of them
have already led or currently lead large-scale genome projects,
such as those at the Sanger Center (UK) and BGI (China). The
community of interested scientists is rapidly growing, and there is
strong international support for this effort (12). In the near future,
representatives from government, private industry, civil society,
international organizations, and private foundations will be inte-
grated into the governance structure of the EBP. Broad represen-
tation in governance is desirable for the EBP’s global public good
mandate to ensure inclusive societal benefits worldwide, and to
establish stable and sustainable funding for accessibility to state-
of-the-art technology in genomics, computing, data science, and
biotechnology.
Several large sequencing centers are supporting the goals
of the EBP, including BGI (China), Baylor College of Medicine
(USA), the Sanger Institute (UK), and Rockefeller University (USA).
The São Paulo Research Foundation (FAPESP), one of the major
research funding organizations in Brazil, will establish an EBP
node in São Paulo to be the initial location serving Latin America,
adding to the global hub-and-spokes model envisioned for the
EBP (Fig. 3). Other institutions and service providers with signifi-
cant sequencing capacity will be encouraged to participate.
If the genomes of Earth’s biome are to be compared and fully
decoded there must be standards for creating, comparing and
analyzing genome assemblies so that the genome information
will be useful to the broadest possible scientific community. The
issue of standards will be particularly challenging to coordinate
across the sequencing and informatics nodes and among the
different taxon-based communities. However, if this is not accom-
plished, the final anticipated outcomes may fall short of project
expectations. To address this issue, authors of this paper (R.D.
and H.L.) have recently developed a set of standards for quality
assessment of whole genome assemblies (see SI Fig. S1). This
standard can be applied to characterizing any whole genome
assembly and can be readily adopted by other communities.
In addition, the G10K community is working on a push-button
assembly pipeline that uses data from a variety of sources to
produce highly contiguous chromosome-scale assemblies. These
approaches can be extended to all the communities comprising
the EBP. An EBP central Coordinating Council, comprised of the
leaders of each network community, and the sequencing and
informatics nodes, will be responsible for developing and pro-
mulgating standards for sequencing, annotation and downstream
analysis (Fig. 3).
A Network of Communities. A growing fraction of biodiver-
sity genome sequencing is being performed by taxon-based
communities of experts, such as the Genome 10K organization
(G10K)(40), i5K (41), B10K (https://b10k.genomics.cn/), GAGA
(http://antgenomics.dk/), and GIGA (42) (see Table 2 for ongoing
genome projects affiliated with the EBP). Groups such as G10K
and i5K have made progress in planning and implementation of
their projects, and have served as a model for the EBP and other
existing and developing groups working across the phylogenetic
spectrum. It is anticipated that the leadership of phylum and
class-level taxonomic groups will become part of the Governing
Council of the EBP, and that the EBP will endeavor to provide
support to all of these projects. The EBP will be a global effort
– a network of communities and individuals – all focused on this
grand challenge.
Total Project Cost & Economic Benefit
With the current cost of $1,000 USD (and plummeting rapidly)
for sequencing an average vertebrate-sized genome to draft
level, genomes of all 1.5 million known eukaryotes, up to
100,000 new eukaryotic species, and a defined number of eDNA
samples from biodiversity hot zone collection sites, can be
sequenced to a high-level of completeness and accuracy for
approximately $4.7 billion USD (SI Table S3). This includes costs
for sequencing instruments, sample collection,9,000 reference-
quality genomes, data storage, analysis, visualization and dissem-
ination, and project management. Incredibly, this is less than the
cost of creating the first draft human genome sequence ($2.7
billion USD) in today’s dollars ($4.8 billion USD)! New funds raised
for the EBP will be leveraged by the hundreds of millions of
dollars already committed to genome projects around the world.
The economic impact of the EBP is likely to be very large
and globally distributed. Using the Human Genome Project as
an example, the return on U.S. federal investment was estimated
at 141:1 in the U.S. alone as of 2012 (9). An entire industry
was created, with a workforce size of more than 47,000 people
generating nearly $1 trillion dollars in economic activity. The
technologies arising from investments in genomics are having
a profound effect on human medicine, veterinary medicine,
renewable energy development, food and agriculture, environ-
mental protection, industrial biotechnology, the justice system
and national security. For example, a recent report of the U.S.
National Academy of Sciences states that annual revenues in the
U.S. from genetically engineered plants and microbes to be least
$300 billion (43). China, the United Kingdom, Canada, France,
Japan and other countries have also made sizable investments
in genomics research and now have mature industries that are
contributing to their national economies.
These economic returns from the Human Genome Project to
date have resulted just from sequencing the human genome and
those of a relatively small number of model organisms. With
less than <0.2% eukaryotic species sequenced to date, there is
significant potential for discoveries that will impact human, animal
and environmental health and the food and agriculture system,
and multiple manufacturing industries. While it is not possible to
predict the economic impact, it is quite reasonable to assume
that sequencing the remaining 99.8% of eukaryotic species will
yield returns similar to or exceeding those of the Human Genome
Project. Importantly, the distribution of much of the world’s
biodiversity in developing regions could bring tremendous eco-
nomic benefits to those countries under the Nagoya Protocol as
discussed above. The EBP will comply with Access and Benefit
Sharing laws through partnerships with organizations such as the
Amazon Third Way Initiative and the Amazon Bank of Codes (44).
Conclusions
The Earth BioGenome Project is arguably the most ambitious
proposal in the history of biology. If successful, the EBP will
completely transform our scientific understanding of life on earth
and provide new resources to cope with the rapid loss of bio-































































































































activities and climate change. Fundamental knowledge of Earth’s
biodiversity may also lead to new food sources, revolutionary
bio-inspired materials, and innovations to treat human, animal,
and plant diseases. Significant challenges remain in executing
the EBP, the most substantial of which are sample acquisition,
the related issue of Access and Benefit Sharing, and funding.
The greatest legacy of the EBP will be the gift of knowledge –
a complete Digital Library of Life – that contains the collective
biological intelligence of 3.5 billion years of evolutionary history.
This knowledge will guide future discoveries for generations and
may ultimately determine the survival of life on our planet.
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